Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential

Area of Science:

• Gastroenterology
• Hepatology
• Oncology

Background:

• Primary sclerosing cholangitis (PSC) is a chronic biliary disease frequently co-occurring with ulcerative colitis (UC).
• PSC is recognized as a potential risk factor for colorectal malignancy in UC patients and increases the risk of cholangiocarcinoma.
• The interplay between PSC, UC, and the development of gastrointestinal and biliary cancers requires further investigation.

Purpose of the Study:

• To evaluate the cumulative risk of colorectal neoplasia in patients with both PSC and UC.
• To identify risk factors associated with the development of cholangiocarcinoma in this patient cohort.
• To compare the incidence of colorectal neoplasia in PSC/UC patients versus UC-only patients.

Main Methods:

• A cohort of 58 PSC patients was analyzed.
• Forty PSC patients with extensive UC were matched with two control patients (extensive UC, no PSC) based on age and disease duration.
• Colonoscopic surveillance with biopsies was performed on all UC patients.

Main Results:

• The cumulative risk of colorectal dysplasia/carcinoma after 10, 20, and 25 years was 9%, 31%, and 50% in the PSC/UC group, versus 2%, 5%, and 10% in the UC-only group (P < .001).
• Sixteen out of 40 PSC/UC patients developed colonic dysplasia or carcinoma, compared to 10 in the control group.
• Ten PSC patients developed cholangiocarcinoma, with a higher incidence observed in those with co-existing colorectal neoplasia (P < .02).

Conclusions:

• Patients with PSC and UC exhibit a substantially elevated risk for colorectal neoplasia compared to UC patients without PSC.
• The presence of colorectal neoplasia in PSC/UC patients is linked to a greater propensity for developing cholangiocarcinoma.
• These findings underscore the importance of vigilant surveillance for both colorectal and biliary malignancies in patients with PSC and UC.